nocodazole has been researched along with ilmofosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grunicke, H; Hofmann, J; Jackman, J; Kohn, KW; O'Connor, PM; Schubert, C; Ueberall, F | 1 |
1 other study(ies) available for nocodazole and ilmofosine
Article | Year |
---|---|
The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents.
Topics: Alkaloids; Antineoplastic Agents; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle; Cell Line; DNA Damage; Dose-Response Relationship, Radiation; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; G2 Phase; Humans; Kinetics; Mechlorethamine; Nocodazole; Phospholipid Ethers; Protein Kinase C; Radiation, Ionizing; Staurosporine; Tumor Cells, Cultured | 1994 |